Physicians underestimate the severity of fatigue, stomatitis, HFS and dysgeusia in mRCC-patients on systemic therapy: Interimanalysis of the Fatigue, Mucositis, Hand-Foot-Syndrome, and Dysgeusia in RCC study (FAMOUS). 31. Mai 2010 Marschner, N., Münch, A., Lerchenmüller, C., Linz, B., Müller, L., 2010. Onkologie 33 (suppl 6)(P203), 58. doi:10.1159/000321407 Abstract Download Impact of adverse drug reactions (ADR) on systemic therapy in patients (pts) with advanced or metastatic renal cell carcinoma (mRCC). Marschner, N., Münch, A., Blumenstengel, K., Sauer, U., Müller, L., 2010. Ann Oncol, Abstract 949 21(suppl 8), viii298. doi:10.1093/annonc/mdq525 Abstract… Weiterlesen Tolerability of different first-line treatment (trt) regimens in patients (pts) with advanced or metastatic renal cell carcinoma (mRCC). Müller, L., Münch, A., Blumenstengel, K., Hutzschenreuther, U., Busies, S., 2010. J Clin Oncol 28(Sup. abstr e15086). doi: 10.1200/jco.2010.28.15_suppl.e15086 Abstract… Weiterlesen